Liquidia (LQDA) Gains from Sales and Divestitures (2020 - 2026)
Liquidia (LQDA) recorded quarterly Gains from Sales and Divestitures of $824292.0 in Q1 2026, down 41.2% quarter-over-quarter from $1.4 million in Q4 2025, and up 99.08% on a YoY basis from $414053.0 in Q1 2025.
Liquidia (LQDA) Gains from Sales and Divestitures (2020 - 2026) Analysis & Trends
Liquidia's Gains from Sales and Divestitures history runs 7 years deep, the most recent figure standing at $824292.0 for Q1 2026.
- In Q1 2026, Gains from Sales and Divestitures rose 99.08% year-over-year to $824292.0; the TTM figure through Mar 2026 stood at $824292.0 (up 99.08% YoY), while the FY2025 annual figure was $1.4 million, up 93.36% from the prior year.
- Gains from Sales and Divestitures was $824292.0 for Q1 2026 at Liquidia, down from $1.4 million in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of $1.4 million in Q4 2025 to a low of $54181.0 in Q4 2022.
- Historically, Gains from Sales and Divestitures has averaged $506531.2 across 5 years, with a median of $383133.0 in 2024.
- Biggest YoY gain for Gains from Sales and Divestitures was 3241.11% in 2022; the steepest drop was 79.95% in 2022.
- A 5-year view of Gains from Sales and Divestitures shows it stood at $54181.0 in 2022, then soared by 272.6% to $201880.0 in 2023, then surged by 259.14% to $725038.0 in 2024, then jumped by 93.36% to $1.4 million in 2025, then slumped by 41.2% to $824292.0 in 2026.
- The last three Gains from Sales and Divestitures figures came in at $824292.0 (Q1 2026), $1.4 million (Q4 2025), and $1.2 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Liquidia | 5.64 Bn | 5.42 Bn | 121.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 824,292.00 |
| Mar 31, 2026 | 824,292.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Sep 30, 2025 | 1.18 Mn |
| Jun 30, 2025 | 942,683.00 |
| Jun 30, 2025 | 942,683.00 |
| Mar 31, 2025 | 414,053.00 |
| Mar 31, 2025 | 414,053.00 |
| Dec 31, 2024 | 725,038.00 |
| Dec 31, 2024 | 725,038.00 |
| Sep 30, 2024 | 615,827.00 |
| Sep 30, 2024 | 615,827.00 |
| Jun 30, 2024 | 499,580.00 |
| Jun 30, 2024 | 499,580.00 |
| Mar 31, 2024 | 383,133.00 |
| Mar 31, 2024 | 383,133.00 |
| Dec 31, 2023 | 201,880.00 |
| Dec 31, 2023 | 201,880.00 |